BridgeMD
New treatment option for Osteoarthritis, Knee
Official title Knowledge Translation and Exercise for Degenerative Meniscal Tears and Early Osteoarthritis: KNEE-DEeP Study
ClinicalTrials.gov ID: NCT06576557
What this study is testing
- What it's testing
- Knee pain due to a degenerative meniscal tear (DMT) or early osteoarthritis (OA) is a frequent presentation in middle-aged and older adults. In the knee joint a DMT can occur normally with age, but is also associated with the continuum of knee OA.
- Time commitment: about 6 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 69
You may be able to join if
- for Participants with Knee Pain:
- Attended their GP with an episode of non-traumatic knee pain
- Have knee pain attributed to a DMT or early degenerative changes based on the GP's clinical assessment (this standardised assessment is a component...
- Aged between 35 and 69 years inclusive
You likely can't join if
- Recent trauma likely to be associated with considerable tissue damage
- Fulfilling the American College of Rheumatology clinical classification criteria for knee OA (these criteria reflect later signs of OA or established...
- Moderate or advanced knee OA on x-ray (or Kellgren-Lawrence x-ray score ≥ Grade 3)
- Having an acutely swollen or locked knee, or suspected ligament injury on physical exam
- Inflammatory arthritis
- Surgery or significant trauma of the index knee within the previous 2 years
See the full eligibility criteria
- for Participants with Knee Pain:
- Attended their GP with an episode of non-traumatic knee pain
- Have knee pain attributed to a DMT or early degenerative changes based on the GP's clinical assessment (this standardised assessment is a component of the GP training)
- Aged between 35 and 69 years inclusive
- Recent trauma likely to be associated with considerable tissue damage
- Fulfilling the American College of Rheumatology clinical classification criteria for knee OA (these criteria reflect later signs of OA or established disease)
- Moderate or advanced knee OA on x-ray (or Kellgren-Lawrence x-ray score ≥ Grade 3)
- Having an acutely swollen or locked knee, or suspected ligament injury on physical exam
- Inflammatory arthritis
- Surgery or significant trauma of the index knee within the previous 2 years
- Pregnancy
- Unable to communicate in English
- Preference for accessing physiotherapy treatment privately prior to the 'best practice' session. Inclusion Criteria for Participating GPs (n=15) and Physiotherapists (n=5):
- Eligible GPs will be working in practices within traveling distance (\< 50 km) of University Hospital Kerry and willing to attend a two-hour training workshop
- Eligible physiotherapists will be involved in the delivery of outpatient musculoskeletal physiotherapy services at University Hospital Kerry and available to participate in training to deliver the 'best practice'...
The study team makes the final eligibility decision.
Where it's taking place
- Tralee, Kerry, Ireland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 69 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tralee, Kerry, Ireland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.